ATE377023T1 - Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene - Google Patents

Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene

Info

Publication number
ATE377023T1
ATE377023T1 AT04818758T AT04818758T ATE377023T1 AT E377023 T1 ATE377023 T1 AT E377023T1 AT 04818758 T AT04818758 T AT 04818758T AT 04818758 T AT04818758 T AT 04818758T AT E377023 T1 ATE377023 T1 AT E377023T1
Authority
AT
Austria
Prior art keywords
melittin
methods
target antigens
containing peptides
immune reactions
Prior art date
Application number
AT04818758T
Other languages
English (en)
Inventor
Rinaldo Zurbriggen
Original Assignee
Pevion Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pevion Biotech Ltd filed Critical Pevion Biotech Ltd
Application granted granted Critical
Publication of ATE377023T1 publication Critical patent/ATE377023T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT04818758T 2003-11-05 2004-11-05 Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene ATE377023T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51750203P 2003-11-05 2003-11-05

Publications (1)

Publication Number Publication Date
ATE377023T1 true ATE377023T1 (de) 2007-11-15

Family

ID=34619323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04818758T ATE377023T1 (de) 2003-11-05 2004-11-05 Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene

Country Status (8)

Country Link
US (1) US7538083B2 (de)
EP (1) EP1680446B1 (de)
AT (1) ATE377023T1 (de)
AU (1) AU2004291277A1 (de)
CA (1) CA2543072A1 (de)
DE (1) DE602004009818T2 (de)
NO (1) NO20062579L (de)
WO (1) WO2005049647A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE377023T1 (de) * 2003-11-05 2007-11-15 Pevion Biotech Ltd Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene
WO2007092315A2 (en) * 2006-02-03 2007-08-16 The Regents Of The University Of California Immunostimulation by cpg oligonucleotide-virus complexes
WO2007099387A1 (en) 2006-03-03 2007-09-07 Mymetics Corporation Virosome-like vesicles comprising gp41-derived antigens
US20090022799A1 (en) * 2006-10-06 2009-01-22 Shikha Pramanik Barman Compositions that contain beta-glucan to be used for the prevention and treatment of disease and methods for their use
CN101668421B (zh) 2006-11-16 2014-05-21 凯制药公司 用于治疗甲状旁腺功能亢进和高钙血症的聚阳离子钙调节肽
ES2729051T3 (es) 2009-07-29 2019-10-30 Kai Pharmaceuticals Inc Agentes terapéuticos para reducir los niveles de hormona paratiroidea
WO2012170955A1 (en) 2011-06-08 2012-12-13 Kai Pharmaceuticals, Inc. Therapeutic agents for regulating serum phosphorus
KR20200099556A (ko) * 2017-12-15 2020-08-24 바이엘 애니멀 헬스 게엠베하 면역자극성 조성물
CN108129560B (zh) * 2017-12-15 2020-04-28 西安交通大学医学院第一附属医院 一种突变蜂毒肽MEL-pep及其应用
WO2019212324A1 (ko) * 2018-05-04 2019-11-07 경희대학교 산학협력단 멜리틴-기반 세포사멸 유발 펩타이드로 m2 유사 종앙관련 대식세포의 표적화
CN114288404A (zh) * 2021-12-20 2022-04-08 浙江洪晟生物科技股份有限公司 一种禽苗用免疫增强剂、二联灭活疫苗及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5235038A (en) * 1991-01-22 1993-08-10 Torry Pines Institute For Molecular Studies Deletion and substitution analogues of melittin peptide
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US5519114A (en) 1993-10-29 1996-05-21 University Of Florida Research Foundation, Inc. Retroviral superantigens, superantigen peptides, and methods of use
WO1996006181A1 (en) * 1994-08-23 1996-02-29 Drug Delivery System Institute, Ltd. Method of modifying protein
WO1998056400A1 (en) * 1997-06-11 1998-12-17 Board Of Regents, The University Of Texas System Anti-inflammatory and other therapeutic, prophylactic or diagnostic uses of synthetic melittin and new related peptides
US6372471B1 (en) * 1998-10-01 2002-04-16 The Rockefeller University Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
CA2441476A1 (en) * 2001-03-02 2002-09-12 Alk-Abello A/S Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
ATE377023T1 (de) * 2003-11-05 2007-11-15 Pevion Biotech Ltd Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene
WO2007099387A1 (en) * 2006-03-03 2007-09-07 Mymetics Corporation Virosome-like vesicles comprising gp41-derived antigens
EP1938835A1 (de) * 2006-12-29 2008-07-02 Pevion Biotech AG Nichtspezifische immunostimulierende Wirkstoffe

Also Published As

Publication number Publication date
DE602004009818D1 (de) 2007-12-13
US20050196383A1 (en) 2005-09-08
DE602004009818T2 (de) 2008-09-18
NO20062579L (no) 2006-06-02
EP1680446B1 (de) 2007-10-31
WO2005049647A3 (en) 2005-08-11
EP1680446A2 (de) 2006-07-19
WO2005049647A2 (en) 2005-06-02
US7538083B2 (en) 2009-05-26
AU2004291277A1 (en) 2005-06-02
CA2543072A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
EP3424524A3 (de) Neuartige nukleinsäuremoleküle
EP4516800A3 (de) Anti-vegf-pflanzenproteinzusammensetzungen und verfahren zur herstellung davon
ATE426412T1 (de) Adjuvante influenza-vakzine
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EA201000424A1 (ru) Антитела к il-23
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
ATE377023T1 (de) Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene
PL375398A1 (en) Immunostimulatory nucleic acids
NO20054170L (no) Antistoff mot human IL-21 reseptor og anvendelser derav
PE20071055A1 (es) Anticuerpos anti mn
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
EP4640282A3 (de) Immunodominante proteine und fragmente bei multipler sklerose
WO2020074908A3 (en) Treatment and prevention of malaria based on the antigen pfrh5 and antibodies against the same
ATE490785T1 (de) Parathormon-antikörper und damit zusammenhängende verfahren
WO2004087073A3 (en) Treatment of demyelinating conditions
WO2019094533A8 (en) Angptl8-binding agents and methods of use thereof
TW200611706A (en) Cytotoxic t lymphocyte
EA202190382A1 (ru) Фармацевтические составы на основе маскированных антител
WO2020102243A3 (en) In-flow photooxygenation of aminothienopyridinones generates novel ptp4a3 phosphatase inhibitors
DE69839943D1 (de) Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
EA200601408A1 (ru) Композиция, способы и применения нового семейства пептидов
MX2011004176A (es) Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo.
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
WO2003093300A3 (en) Anti-microbial peptides and compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties